β-Sitosterol modulates TLR4 receptor expression and intracellular MyD88-dependent pathway activation in J774A.1 murine macrophages von Valerio, M.S., Minderman, H., Mace, T., Awad, A.B.

Volltext

2402 Sorafenib (SOR) dose reduction attenuates its immunosuppressive effects and delays hepatocellular cancer (HCC) development in the woodchuck model of hepatitis B related HCC von Iyer, R, Patel, P, Buitrago, S, Curtin, L, Fetterly, G, Maguire, O, Minderman, H, Toshkov, I, Tennant, B, Hutson, A, Johnson, C

Volltext

Breast cancer resistance protein (BCRP MXR ABCG2) in acute myeloid leukemia: discordance between expression and function von Suvannasankha, A, Minderman, H, O'Loughlin, K L, Nakanishi, T, Greco, W R, Ross, D D, Baer, M R

Volltext

Cyclosporin A Is a Broad-Spectrum Multidrug Resistance Modulator von Qadir, Misbah, O'Loughlin, Kieran L, Fricke, Stacy M, Williamson, Nicole A, Greco, William R, Minderman, Hans, Baer, Maria R

Volltext

1195P - Safety, efficacy, and immune effects of intratumoral tilsotolimod in patients with refractory solid tumours: Updated results from ILLUMINATE-101 von Babiker, H., Borazanci, E., Subbiah, V., Maguire, O., Rahimian, S., Minderman, H., Haymaker, C., Bernatchez, C., Bindra, G., Iverson, I., Chunduru, S., Anderson, P., Puzanov, I., Diab, A.

Volltext

1195PSafety, efficacy, and immune effects of intratumoral tilsotolimod in patients with refractory solid tumours: Updated results from ILLUMINATE-101 von Babiker, H, Borazanci, E, Subbiah, V, Maguire, O, Rahimian, S, Minderman, H, Haymaker, C, Bernatchez, C, Bindra, G, Iverson, I, Chunduru, S, Anderson, P, Puzanov, I, Diab, A

Volltext

Safety, efficacy, and immune effects of intratumoral tilsotolimod in patients with refractory solid tumours: Updated results from ILLUMINATE-101 von Babiker, H., Borazanci, E., Subbiah, V., Maguire, O., Rahimian, S., Minderman, H., Haymaker, C., Bernatchez, C., Bindra, G., Iverson, I., Chunduru, S., Anderson, P., Puzanov, I., Diab, A.

Volltext

VX-710 (Biricodar) Increases Drug Retention and Enhances Chemosensitivity in Resistant Cells Overexpressing P-Glycoprotein, Multidrug Resistance Protein, and Breast Cancer Resistan... von MINDERMAN, Hans, O'LOUGHLIN, Kieran L, PENDYALA, Lakshmi, BAER, Maria R

Volltext

1031P Tilsotolimod engages the TLR9 pathway to promote antigen presentation and type I IFN signaling in solid tumours von Babiker, H., Borazanci, E., Subbiah, V., Algazi, A.P., Schachter, J., Lotem, M., Hendler, D., Rahimian, S., Minderman, H., Haymaker, C., Bernatchez, C., Murthy, R., Hultsch, R., Caplan, N., Woodhead, G.J., Hennemeyer, C.T., Chunduru, S., Anderson, P., Diab, A., Puzanov, I.

Volltext

P-156 A phase Ib/II study of cetuximab and pembrolizumab in metastatic colorectal cancer von Fountzilas, C., Mukherjee, S., Saltzman, J., Bajor, D., Muhitch, J., Abrams, S., Maguire, O., Minderman, H., Wang, K., Hutson, A., Hicks, K., Ventola, J., Kalinski, P., Iyer, R., Boland, P.

Volltext

Neem oil limonoids induces p53-independent apoptosis and autophagy von SRIVASTAVA, Pragya, YADAV, Neelu, CHANDRA, Dhyan, LELLA, Ravi, SCHNEIDER, Andrea, JONES, Anthony, MARLOWE, Timothy, LOVETT, Gabrielle, O'LOUGHLIN, Kieran, MINDERMAN, Hans, GOGADA, Raghu

Volltext

Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Stud... von Baer, Maria R., George, Stephen L., Dodge, Richard K., O'Loughlin, Kieran L., Minderman, Hans, Caligiuri, Michael A., Anastasi, John, Powell, Bayard L., Kolitz, Jonathan E., Schiffer, Charles A., Bloomfield, Clara D., Larson, Richard A.

Volltext

Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein von Brooks, Tracy A, Minderman, Hans, O'Loughlin, Kieran L, Pera, Paula, Ojima, Iwao, Baer, Maria R, Bernacki, Ralph J, Brooks, Tracy

Volltext

d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors von U Vanhoefer, S Cao, H Minderman, K Toth, B S Skenderis, 2nd, M L Slovak, Y M Rustum

Volltext

PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein von VANHOEFER, U, SHOUSONG CAO, MINDERMAN, H, TOTH, K, SCHEPER, R. J, SLOVAK, M. L, RUSTUM, Y. M

Volltext

Response to letter from Dr Domenico Ribatti von Bunworasate, U, Arnouk, H, Minderman, H, O'Loughlin, K.L, Sait, S.N.J, Barcos, M, Stewart, C.C, Baer, M.R

Volltext

Idarubicin DNA intercalation is reduced by MRP1 and not Pgp von SMEETS, M. E. P, RAYMAKERS, R. A. P, VIERWINDEN, G, PENNINGS, A. H. M, BOEZEMAN, J, MINDERMAN, H, DE WITTE, T. M

Volltext

Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease‐free survival von Suvannasankha, Attaya, Minderman, Hans, O'Loughlin, Kieran L., Nakanishi, Takeo, Ford, Laurie A., Greco, William R., Wetzler, Meir, Ross, Douglas D., Baer, Maria R.

Volltext

Broad-spectrum modulation of ATP-binding cassette transport proteins by the taxane derivatives ortataxel (IDN-5109, BAY 59-8862) and tRA96023 von MINDERMAN, Hans, BROOKS, Tracy A, O'LOUGHLIN, Kieran L, OJIMA, Iwao, BERNACKI, Ralph J, BAER, Maria R

Volltext

In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells von Minderman, Hans, Conroy, Jeffrey M, O'Loughlin, Kieran L, McQuaid, Devin, Quinn, Paul, Li, Song, Pendyala, Lakshmi, Nowak, Norma J, Baer, Maria R

Volltext